Ardelyx, Inc. financial data

Symbol
ARDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
34175 Ardenwood Blvd., Fremont, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
NTERYX INC (to 6/9/2008)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 473 % +90.1%
Quick Ratio 122 % +125%
Debt-to-equity 94.1 % +11.5%
Return On Equity -39.7 % +26.7%
Return On Assets -20.5 % +30.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 235M shares +8.06%
Common Stock, Shares, Outstanding 235M shares +8.05%
Entity Public Float 725M USD +712%
Common Stock, Value, Issued 23K USD +4.55%
Weighted Average Number of Shares Outstanding, Basic 235M shares +9.13%
Weighted Average Number of Shares Outstanding, Diluted 235M shares +9.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 210M USD +153%
Cost of Revenue 5.57M USD +6452%
Research and Development Expense 41.5M USD +22.1%
Costs and Expenses 240M USD +89.7%
Operating Income (Loss) -58.9M USD -12.3%
Nonoperating Income (Expense) 8.27M USD +110%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -64.4M USD -14.9%
Income Tax Expense (Benefit) 721K USD +5050%
Net Income (Loss) Attributable to Parent -65.1M USD -16.1%
Earnings Per Share, Basic -0.27 USD/shares -17.4%
Earnings Per Share, Diluted -0.27 USD/shares -17.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 41.9M USD +39.4%
Accounts Receivable, after Allowance for Credit Loss, Current 37.2M USD +309%
Inventory, Net 83.4M USD +74.1%
Assets, Current 263M USD +62.2%
Property, Plant and Equipment, Net 1.02M USD -4.51%
Operating Lease, Right-of-Use Asset 4.32M USD -38.7%
Other Assets, Noncurrent 5.45M USD +710%
Assets 343M USD +62.6%
Accounts Payable, Current 10.9M USD +106%
Employee-related Liabilities, Current 10.5M USD +52%
Contract with Customer, Liability, Current 10.8M USD +81.7%
Liabilities, Current 62.4M USD +1.21%
Contract with Customer, Liability, Noncurrent 9.61M USD +4.06%
Operating Lease, Liability, Noncurrent 1.1M USD -70.8%
Other Liabilities, Noncurrent 170K USD
Liabilities 196M USD +123%
Accumulated Other Comprehensive Income (Loss), Net of Tax -101K USD +51.9%
Retained Earnings (Accumulated Deficit) -889M USD -7.91%
Stockholders' Equity Attributable to Parent 147M USD +19.3%
Liabilities and Equity 343M USD +62.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.7M USD +20.3%
Net Cash Provided by (Used in) Financing Activities 53M USD +4.03%
Net Cash Provided by (Used in) Investing Activities -2.57M USD +73.7%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 235M shares +8.05%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.9M USD +39.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +144%
Deferred Tax Assets, Valuation Allowance 196M USD +11.7%
Deferred Tax Assets, Gross 198M USD +11.1%
Operating Lease, Liability 4.65M USD -40.9%
Depreciation 232K USD -45%
Payments to Acquire Property, Plant, and Equipment 150K USD +971%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -65M USD -15.7%
Lessee, Operating Lease, Liability, to be Paid 4.87M USD -42%
Property, Plant and Equipment, Gross 11.2M USD +3.03%
Operating Lease, Liability, Current 3.55M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 604K USD -54.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.66M USD -63.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 225K USD -58.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 117K USD -53.6%
Deferred Tax Assets, Operating Loss Carryforwards 98.7M USD +14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 23.6M USD -1.87%
Lessee, Operating Lease, Liability, to be Paid, Year Four 252K USD -80.9%
Operating Lease, Payments 4.67M USD +6.91%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 435K USD
Deferred Tax Assets, Net of Valuation Allowance 1.36M USD -36.2%
Share-based Payment Arrangement, Expense 25.8M USD +159%
Interest Expense 6.28M USD +70.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%